Annual Retained Earnings
-$909.10 M
-$55.19 M-6.46%
December 31, 2023
Summary
- As of February 8, 2025, TBPH annual retained earnings is -$909.10 million, with the most recent change of -$55.19 million (-6.46%) on December 31, 2023.
- During the last 3 years, TBPH annual retained earnings has risen by +$617.51 million (+40.45%).
- TBPH annual retained earnings is now -5236.68% below its all-time high of -$17.04 million, reached on December 31, 2013.
Performance
TBPH Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$950.00 M
-$12.70 M-1.35%
September 30, 2024
Summary
- As of February 8, 2025, TBPH quarterly retained earnings is -$950.00 million, with the most recent change of -$12.70 million (-1.35%) on September 30, 2024.
- Over the past year, TBPH quarterly retained earnings has dropped by -$49.40 million (-5.49%).
- TBPH quarterly retained earnings is now -5476.72% below its all-time high of -$17.04 million, reached on December 31, 2013.
Performance
TBPH Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
TBPH Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.5% | -5.5% |
| 3 y3 years | +40.5% | +43.9% |
| 5 y5 years | +10.2% | +37.8% |
TBPH Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.5% | +47.3% | -12.6% | +46.0% |
| 5 y | 5-year | -6.5% | +47.3% | -12.6% | +46.0% |
| alltime | all time | -5236.7% | +47.3% | -5476.7% | +46.0% |
Theravance Biopharma Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$950.00 M(+1.4%) |
| Jun 2024 | - | -$937.30 M(+1.8%) |
| Mar 2024 | - | -$920.77 M(+1.3%) |
| Dec 2023 | -$909.10 M(+6.5%) | -$909.10 M(+0.9%) |
| Sep 2023 | - | -$900.59 M(+1.0%) |
| Jun 2023 | - | -$891.64 M(+1.8%) |
| Mar 2023 | - | -$876.00 M(+2.6%) |
| Dec 2022 | -$853.91 M(-50.5%) | -$853.91 M(+1.2%) |
| Sep 2022 | - | -$843.55 M(-52.1%) |
| Jun 2022 | - | -$1.76 B(+0.5%) |
| Mar 2022 | - | -$1.75 B(+1.5%) |
| Dec 2021 | -$1.73 B(+13.1%) | -$1.73 B(+1.9%) |
| Sep 2021 | - | -$1.69 B(+2.1%) |
| Jun 2021 | - | -$1.66 B(+3.3%) |
| Mar 2021 | - | -$1.61 B(+5.2%) |
| Dec 2020 | -$1.53 B(+22.3%) | -$1.53 B(+4.0%) |
| Sep 2020 | - | -$1.47 B(+5.3%) |
| Jun 2020 | - | -$1.39 B(+4.7%) |
| Mar 2020 | - | -$1.33 B(+6.7%) |
| Dec 2019 | -$1.25 B | -$1.25 B(+5.5%) |
| Sep 2019 | - | -$1.18 B(+5.2%) |
| Jun 2019 | - | -$1.12 B(+3.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -$1.08 B(+7.2%) |
| Dec 2018 | -$1.01 B(+26.9%) | -$1.01 B(+5.2%) |
| Sep 2018 | - | -$961.96 M(+6.6%) |
| Jun 2018 | - | -$902.53 M(+4.7%) |
| Mar 2018 | - | -$861.71 M(+8.0%) |
| Dec 2017 | -$797.74 M(+55.7%) | -$797.74 M(+12.2%) |
| Sep 2017 | - | -$710.82 M(+10.4%) |
| Jun 2017 | - | -$643.94 M(+11.5%) |
| Mar 2017 | - | -$577.65 M(+12.8%) |
| Dec 2016 | -$512.23 M(+59.3%) | -$512.23 M(+15.1%) |
| Sep 2016 | - | -$444.89 M(+8.3%) |
| Jun 2016 | - | -$410.93 M(+13.0%) |
| Mar 2016 | - | -$363.71 M(+13.1%) |
| Dec 2015 | -$321.56 M(+130.8%) | -$321.56 M(+16.2%) |
| Sep 2015 | - | -$276.73 M(+20.6%) |
| Jun 2015 | - | -$229.41 M(+26.2%) |
| Mar 2015 | - | -$181.81 M(+30.5%) |
| Dec 2014 | -$139.34 M(+717.9%) | -$139.34 M(+85.7%) |
| Sep 2014 | - | -$75.03 M(+265.4%) |
| Jun 2014 | - | -$20.53 M(+14.6%) |
| Mar 2014 | - | -$17.92 M(+5.2%) |
| Dec 2013 | -$17.04 M | -$17.04 M |
FAQ
- What is Theravance Biopharma annual retained earnings?
- What is the all time high annual retained earnings for Theravance Biopharma?
- What is Theravance Biopharma annual retained earnings year-on-year change?
- What is Theravance Biopharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for Theravance Biopharma?
- What is Theravance Biopharma quarterly retained earnings year-on-year change?
What is Theravance Biopharma annual retained earnings?
The current annual retained earnings of TBPH is -$909.10 M
What is the all time high annual retained earnings for Theravance Biopharma?
Theravance Biopharma all-time high annual retained earnings is -$17.04 M
What is Theravance Biopharma annual retained earnings year-on-year change?
Over the past year, TBPH annual retained earnings has changed by -$55.19 M (-6.46%)
What is Theravance Biopharma quarterly retained earnings?
The current quarterly retained earnings of TBPH is -$950.00 M
What is the all time high quarterly retained earnings for Theravance Biopharma?
Theravance Biopharma all-time high quarterly retained earnings is -$17.04 M
What is Theravance Biopharma quarterly retained earnings year-on-year change?
Over the past year, TBPH quarterly retained earnings has changed by -$49.40 M (-5.49%)